Actavis agreed to acquire rival drug maker Forest Laboratories in a deal worth as much as $25 billion.» Read More
Even in this anemic market, it appears the urge to merge is alive and well.
This could be the greatest comeback in corporate history: a formerly bankdrupt company that has seen customers, revenues, and profits all growing at double digits—and a stock that could soon go public through an unusual method.
Here's our Fast Money Final Trade. Our gang gives you Monday's best trades, right now!
The past 14 days have left the financial industry wounded like never before. Who are the new winners on Wall Street?
CNBC has learned that an historic meeting is planned for Thursday evening to discuss the financial and housing crisis. What’s the word on the Street?
Following are the week’s biggest winners and losers. Find out why shares of Campbell‘s and Amgen popped while Buffalo Wild Wings and GameStop dropped.
The Dow closed modestly higher on Wednesday after the Federal Reserve held its key interest rate steady. What's the "Word on the Street?"
In Tuesday’s Web Extra find out how to play the steep decline in home prices. Also could this be a summer of private equity deal making?
Following are the day’s biggest winners and losers. Find out why shares of Ford and Staples popped while iRobot and Apache dropped.
With big media earnings due this week, find out what former Disney Chief Michael Eisner says every trader should know! That, plus our other "Trade Tomorrow" plays!
A fresh wave of economic worry swept across Wall Street, aggravated by a spike in wholesale prices, dismaying corporate results, and oil trading above $100 a barrel.
Large-cap growth stocks, especially in the technology sector, are where investors ought to be putting their money right now, according to Jason Trennert. But the chief investment strategist and managing partner at Strategas Research Partners also holds financials -- very selectively.
What are your best trades if M&A activity bounces back in 2008?
Proxy fights are likely to surge this year as investors demand leaner, meaner companies. What are your best plays as companies and activists battle for control?